1 / 3

Global 3D Bioprinting Market is anticipated to reach at market value of US$ 1.4 Bn by 2027

As per the report, Global 3D Bioprinting Market was valued at US$ 623 Mn in 2018 and it is anticipated to reach at market value of US$ 1.4 Bn by 2027, witnessing a CAGR of 18.6 % during the forecast period.

Download Presentation

Global 3D Bioprinting Market is anticipated to reach at market value of US$ 1.4 Bn by 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global 3D Bioprinting Market is anticipated to reach at market value of US$ 1.4 Bn by 2027 Bizizz Market Research has recently published a research report, “3D Bioprinting Market By Component (3D Bioprinters (Magnetic 3d bioprinting, Laser-assisted bioprinting, Inkjet 3d bioprinting, Micro extrusion Bioprinters, and Other) Bioprinters Bio inks (Natural bio inks, Synthetic bio inks, and Hybrid bio inks)), Material (Hydrogels, Extracellular Matrices, Living Cells, and Other Biomaterials), Application (Research Applications (Drug Research, Regenerative Medicine, 3d Cell Culture) Clinical Applications (Skin, Bone & Cartilage, Blood Vessels, and Others), End User (Hospitals, Research Organizations and Academic Institutes Biopharmaceutical, and Companies), and Region-Global Industry Trends, Estimation & Forecast, 2019 - 2027”. As per the report, Global 3D Bioprinting Market was valued at US$ 623 Mn in 2018 and it is anticipated to reach at market value of US$ 1.4 Bn by 2027, witnessing a CAGR of 18.6 % during the forecast period. Key drivers of the market are increasing prevalence of chronic disorders like kidney and heart failures, growing elderly populace, and the insufficient number of organ donors. However, dearth of skilled professionals may hinder the growth of the market during the forecast period. 3D bioprinting technology has witnessed accelerated adoption in the healthcare industry. Bioprinting has emerged as a promising technological know-how for the fabrication of synthetic tissues and organs, which can revolutionize the analysis and cure of more than a few scientific conditions. Bioprinting businesses around the world are constantly innovating in regenerative medicine, tissue engineering, drug therapies, and stem cell therapy, which is gaining attention from healthcare authorities and pharmaceutical agencies to envision a future with higher patient care, custom-made medical treatment, and an alternative to organ transplantation. Over the previous few years, essential technological advancements in the 3D bioprinting space have taken place for numerous scientific applications, inclusive of skin tissue development, most cancers therapeutics, bone and cartilage development, and liver modeling. Advanced technologies grant players with a competitive area and thereby help in strengthening their

  2. function and share in the market. For instance, in 2018, Poietis (France) launched the 3D bioprinted pores and skin model, Poieskin. The total human pores and skin model is made by using the bioprinting of essential human collagen and fibroblast for the dermal layer and major human keratinocytes for the epidermal layer. The 3D Bioprinting market is anticipated to register a CAGR of over 18.6% during the forecast period. To Have A Glimpse Of The Report Or To Avail The Free Sample Click The Link Below: https://bizizzmarketresearch.com/report/global-overview-of-3d-bioprinting-market By Material, the living cells segment held a prominent share in Global 3D Bioprinting Market in 2018. On the basis of material, the 3D bioprinting market is segmented into hydrogels, extracellular matrices, living cells, and other biomaterials. In 2018, the living cells segment accounted for the biggest market share particularly due to the developing R&D in the fields of regenerative medicine and stem cell research, and increasing public and personal investments to help research By Application, Skin Printing Segment of Global 3D Bioprinting Market Is Anticipated To Witness the Fastest CAGR during the Forecast Period The clinical applications market is similarly segmented into skin printing, bone & cartilage printing, blood vessel printing, and other scientific applications. Among these, the pores and skin printing purposes segment is estimated to develop at the best CAGR of 19.8% in the course of the forecast period. This can be attributed to the technological developments and new product launches in this utility segment, and the growing wide variety of aesthetic and reconstruction surgeries across the globe. North America is anticipated to dominate the Global 3D Bioprinting Market during the Forecast Period Growing target populace base is in all likelihood to be the crucial cause boosting the region’s 3D bioprinting market growth. The existence of well-established corporations and subtle healthcare set-up in consort with high income tiers in the location are also anticipated through the market development. Moreover, huge research and improvement activities carried out inside the place are said to make contributions to market expansion. Additionally, the accessibility of 3D printed drugs that can be tailor-made in accordance with the age and body weight of a person is supporting to boost up the market evolution. Global 3D Bioprinting market was highly consolidated with key players accounting for significant share in 2018. Prominent players operating in the Global 3D Bioprinting Market are: Solidscape, Inc. (acquired by Prodways Group), TeVido BioDevices, LLC, 3Dynamics Systems Ltd., Bio3D Technologies Pte. Ltd., Aspect Biosystems Ltd., Stratasys Ltd., Luxexcel Group B.V., Materialise N.V., Cyfuse Biomedical K.K., Voxeljet A.G., Envision TEC, and Organovo Holding, Inc., among others. About Bizizz Market Research:

  3. Bizizz Market Research (BMR) is a unique market research, consulting, and business solution organization that offers best strategic and tactical support to customers to enhance their business decision process. BMR team is full of impassioned & dedicated experts who thrives to give their very best to their clients and always ready to take any challenge. Our expanding team of professionals & experts from a wide array of streams and vertical has critical problem solving skills, innovative approaches and research techniques to deliver best solution to our clients. We continuously pushing our capabilities to enhance our services and setting higher quality goals each day. BMR offers syndicated reports, custom reports and consulting services to our clients. We are capable of catering the market research demands of individuals and organizations of various industries across different geographies with utmost data accuracy in minimal turnaround time. Contact Us: Bizizz Market Research 410 E Santa Clara Street, Unit #762 San Jose, CA 95113 Phone: +1 408-622-0123 Email: sales@bizizzmarketresearch.com Website: www.bizizzmarketresearch.com

More Related